MCP Tips for better browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 1, 2007.
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600303-MCP200v1
6/5/755    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vissers, J. P. C.
Right arrow Articles by Aerts, J. M. F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vissers, J. P. C.
Right arrow Articles by Aerts, J. M. F. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on August 9, 2006
Revised on December 8, 2006
Accepted on February 9, 2007

Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease

Johannes P. C. Vissers, James I. Langridge, and Johannes M. F. G. Aerts

Waters Corporation, Manchester, Greater Manchester M225PP

Corresponding Author: hans_vissers{at}waters.com

Novel approaches for the qualitative and quantitative proteomic analysis by nanoscale LC-MS ap-plied to the study of protein expression response in depleted and undepleted serum of Gaucher patients under going enzyme replacement therapy are presented. Particular emphasis is given to the method reproducibility of these LC-MS experiments without the use of isotopic labels. The level of chitotriosidase – an established Gaucher biomarker – was assessed by means of an abso-lute concentration determination technique for alternate scanning LC-MS generated data. Disease associated proteins – including fibrinogens, complement cascade proteins, and members of the high-density lipoprotein serum content – were recognized by various clustering methods and sorting and intensity profile grouping of identified peptides. Condition unique LC-MS protein sig-natures could be generated utilizing the measured serum protein concentrations and are pre-sented for all investigated conditions. The clustering results of the study have also been used as input for gene ontology searches to determine the correlation between the molecular functions of the identified peptides and proteins.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Brief Funct Genomic ProteomicHome page
M. Wang, J. You, K. G. Bemis, T. J. Tegeler, and D. P. G. Brown
Label-free mass spectrometry-based protein quantification technologies in proteomic analysis
Brief Funct Genomic Proteomic, June 25, 2008; (2008) eln031v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.